Who Paid My Doc
Jeffrey Arle
Neurological Surgery Burlington, MA Medical Doctor
NPI 1528169851 CMS profile 23439
Lahey Clinic INC, 41 Mall Road, Burlington, MA 01805
General payments
$283,793
Research payments
$1,939
Ownership & investment interest
$0
Research they led as principal investigator
$131,250
Through program year 2025, Jeffrey Arle of Burlington, MA is reported in the CMS Open Payments database as having received $283,793 across 278 general payments and $1,939 in research payments paid to them. Separately, studies naming them as principal investigator received $131,250 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
9 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $19,500 | 51 | |
| 2024 | General | $1,222 | 14 | |
| 2023 | General | $830 | 9 | |
| 2022 | General | $46,245 | 23 | |
| 2021 | General | $38,027 | 50 | |
| 2020 | General | $12,347 | 39 | |
| 2020 | Research | $1,788 | 1 | |
| 2019 | General | $165,621 | 92 | |
| 2019 | Research | $151 | 2 |
Beside peers
- Jeffrey Arle
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Jeffrey Arle were reported at $19,500. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Jeffrey Arle | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $165,621 | $582 | $138–$3,006 | $163 |
| 2020 | $12,347 | $294 | $76–$2,174 | $114 |
| 2021 | $38,027 | $387 | $105–$2,432 | $132 |
| 2022 | $46,245 | $542 | $139–$2,989 | $149 |
| 2023 | $830 | $534 | $145–$2,697 | $160 |
| 2024 | $1,222 | $574 | $155–$3,046 | $164 |
| 2025 | $19,500 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$15,425
Medicare patients
36
Services billed
58
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 58% | |
| Diabetes | 50% | |
| Depression | 50% | |
| Ischemic heart disease | 36% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
281 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in Massachusetts
Related records
Neurological Surgery in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.